2898 — Sunho Biologics Balance Sheet
0.000.00%
Last trade - 00:00HealthcareMid Cap
- HK$10.55bn
- HK$10.53bn
- CNY56.13m
Annual balance sheet for Sunho Biologics, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.
2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|
| Period Length: | — | — | — |
| Source: | PROSPECTUS | PROSPECTUS | ARS |
| Standards: | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final |
| Cash and Equivalents | |||
| Short Term Investments | |||
| Cash and Short Term Investments | 1.82 | 210 | 457 |
| Net Total Receivables | 1 | 0.999 | 6.13 |
| Total Inventory | |||
| Prepaid Expenses | |||
| Total Other Current Assets | |||
| Total Current Assets | 14.6 | 227 | 493 |
| Gross Property, Plant And Equipment | |||
| Accumulated Depreciation | |||
| Net Property, Plant And Equipment | 46.2 | 50.8 | 54.3 |
| Net Intangible Assets | |||
| Long Term Investments | |||
| Other Long Term Assets | |||
| Total Assets | 70.9 | 290 | 561 |
| Accrued Expenses | |||
| Notes Payable / Short Term Debt | |||
| Current Portion of Long Term Debt / Capital Leases | |||
| Total Other Current Liabilities | |||
| Total Current Liabilities | 66.2 | 388 | 44.1 |
| Long Term Debt | |||
| Capital Lease Obligations | |||
| Total Long Term Debt | |||
| Total Debt | |||
| Total Liabilities | 72.4 | 395 | 48.8 |
| Common Stock | |||
| Additional Paid In Capital | |||
| Retained Earnings (Accumulated Deficit) | |||
| Treasury Stock | |||
| Total Equity | -1.5 | -104 | 512 |
| Total Liabilities & Shareholders' Equity | 70.9 | 290 | 561 |
| Total Common Shares Outstanding |